Business / Finance

RSS

Pinnacle Anesthesia to become founding partner in U.S. Anesthesia Partners

Pinnacle Anesthesia today announced it will become a founding partner in U.S. Anesthesia Partners, an anesthesia-focused physician services organization.

7 Jan 2014

Ossianix forms strategic research partnership with Lundbeck

Ossianix, Inc. today announced a strategic research collaboration with Lundbeck A/S. This collaboration follows a previous investment in 2012. The collaboration uses Ossianix's innovative single domain antibody platform based on the shark VNAR structure and will focus on two projects.

6 Jan 2014

Portage acquires approximately 54% equity in Biohaven

Portage Biotech Inc., is pleased to announce that it has acquired approximately 54% equity in Biohaven Pharmaceutical Holding Company Limited, a private corporation formed under the laws of the British Virgin Islands, for $3.5 million, payable as $1.75 million upfront and the balance in three installments over the next eleven months.

6 Jan 2014

Johns Hopkins Kimmel Cancer Center scientists to receive $90M in new funding for cancer research

cientists at the Johns Hopkins Kimmel Cancer Center will receive $90 million in new funding as part of a $540 million gift from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig, to six U.S. institutions. The new award is among the largest for a single private gift to cancer research.

6 Jan 2014

Acadia Healthcare expands geographic presence in the US

Acadia Healthcare Company, Inc. today announced the acquisition of inpatient psychiatric facilities in Seattle, Washington, and Riverside, California, expanding the Company's geographic presence to two new states. Effective, December 1, 2013, the Company completed the purchase of an acute inpatient psychiatric facility from Highline Medical Center, a nonprofit healthcare system headquartered in Seattle.

6 Jan 2014

Thermo Fisher Scientific agrees to sell three businesses to GE Healthcare for $1.06 billion

Thermo Fisher Scientific, the world leader in serving science, today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company, for approximately $1.06 billion. The businesses will become part of GE Healthcare's Life Sciences division.

6 Jan 2014

Cord Blood America achieves AABB accreditation for cell therapy activity

Cord Blood America, Inc. today announced it has achieved AABB accreditation for cell therapy activity associated with cord blood processing, storage and distribution.

6 Jan 2014

BioLife Solutions announces preliminary revenue of $9 million for 2013

BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced preliminary revenue of $9.0 million for the full year 2013.

6 Jan 2014

Aratana Therapeutics announces acquisition of Okapi Sciences NV

Aratana Therapeutics, Inc., a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it has acquired Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases.

6 Jan 2014

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious diseases.

6 Jan 2014

Henry Schein signs agreement to acquire five companies from Arseus

Henry Schein, Inc., the world's largest provider of healthcare products and services to office-based dental, animal health and medical practitioners, today announced the signing of an agreement that will further strengthen its European dental and technology businesses.

6 Jan 2014

Metabolon raises $15 million in Series E financing

Metabolon, Inc., a world leader in metabolomics-based diagnostic tests and research services, announced today that it has raised $15 million in a Series E financing through the issuance of preferred stock.

3 Jan 2014

Marina Biotech, Mirna modify license agreement regarding development of microRNA-based therapeutics

Marina Biotech, Inc., a leading oligonucleotide-based drug discovery and development company, and Mirna Therapeutics, Inc., a privately-held biotechnology company pioneering microRNA replacement therapy for cancer, announced today that they have amended their license agreement regarding the development and commercialization of microRNA-based therapeutics utilizing Mirna's proprietary microRNAs and Marina Biotech's novel SMARTICLES liposomal delivery technology.

3 Jan 2014

AstraZeneca to take over Probiodrug's CDK9 inhibitor program

Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.

3 Jan 2014

Lhasa purchases Granary Wharf House for new international Headquarters

Lhasa Limited, a leading global supplier of knowledge-based software and associated databases for use in toxicity, metabolism and the related sciences, today announces the purchase of Granary Wharf House, Leeds, as its new international Headquarters.

3 Jan 2014

MassRoots closes $150,000 in seed investment from members of ArcView Group

MassRoots, the social network for the medical cannabis community, is pleased to announce it has closed $150,000 in seed investment from members of the ArcView Group. The funding comes on the heels of MassRoots surpassing 25,000 active users and facilitating more than 28 million photo views in the month of December alone.

3 Jan 2014

Numotion partners with The ALS Association to support individuals affected by Lou Gehrig's Disease

Numotion, the complex wheelchair company committed to serving the lifelong needs of people through individualized health and mobility solutions, has partnered with The ALS Association to offer support and enhance the quality of life for individuals affected by amyotrophic lateral sclerosis (ALS).

3 Jan 2014

Physicians Realty Trust closes previously announced mezzanine loan of $6.9 million

Physicians Realty Trust, a self-managed healthcare properties REIT, announced today that it has closed its previously announced mezzanine loan of approximately $6.9 million to affiliates controlled by MedProperties Holdings, LLC, a leading Dallas-based private investor in healthcare real estate (the "Loan").

3 Jan 2014

Five Star Quality Care transfers operations of two rehabilitation hospitals to Reliant-affiliated entities

Five Star Quality Care, Inc. today announced that effective December 31, 2013, it has transferred the operations of two rehabilitation hospitals to entities affiliated with Reliant Hospital Partners, LLC of Richardson, TX.

3 Jan 2014

Advocate Health Care renews performance improvement relationship with MedAssets

MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.

3 Jan 2014